Abstract
1 Ten healthy male volunteers participated in a double-blind placebo-controlled crossover comparison of the pharmacodynamic profiles of single oral doses of diclofensine 25 mg and 50 mg, nomifensine 75 mg and amitriptyline 50 mg. 2 Diclofensine did not influence salivary flow or consistently affect pupil diameter and had no significant effect on subjective measurements of sedation and mood. It had no effect on reaction time, or on critical flicker frequency. 3 By contrast, amitriptyline significantly reduced salivary flow, produced significant sedation and impairment of mood, prolonged reaction time, and appeared to decrease (but not significantly) critical flicker frequency. 4 Nomifensine significantly reduced (i.e. improved) reaction time, and inhibited salivary flow. 5 Diclofensine did not significantly influence heart rate, blood pressure, systolic time intervals or high speed electrocardiogram. 6 No significant treatment-related differences were observed in serum prolactin, cortisol or growth hormone levels.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burgess C. D., Turner P., Wadsworth J. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br J Clin Pharmacol. 1978;5 (Suppl 1):21S–28S. [PMC free article] [PubMed] [Google Scholar]
- Chan M. Y., Ehsanullah R., Wadsworth J., McEwen J. A comparison of the pharmacodynamic profiles of nomifensine and amitriptyline in normal subjects. Br J Clin Pharmacol. 1980 Mar;9(3):247–253. doi: 10.1111/j.1365-2125.1980.tb04834.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cherpillod C., Omer L. M. A controlled trial with diclofensine, a new psychoactive drug, in the treatment of depression. J Int Med Res. 1981;9(5):324–329. doi: 10.1177/030006058100900505. [DOI] [PubMed] [Google Scholar]
- Hindmarch I., Parrott A. C. Repeated dose comparison of nomifensine, imipramine and placebo on subjective assessments of sleep and objective measures of psychomotor performance. Br J Clin Pharmacol. 1977;4(Suppl 2):167S–173S. doi: 10.1111/j.1365-2125.1977.tb05747.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kingsley P. J., Turner P. Class experiment in clinical pharmacology with benzilonium bromide, an anticholinergic drug. Eur J Clin Pharmacol. 1974;7(2):141–143. doi: 10.1007/BF00561329. [DOI] [PubMed] [Google Scholar]
- Kulshrestha V. K., Gupta P. P., Turner P., Wadsworth J. Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol. 1978 Jul;6(1):25–29. doi: 10.1111/j.1365-2125.1978.tb01677.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Omer L. M. Pilot trials with diclofensine, a new psychoactive drug in depressed patients. Int J Clin Pharmacol Ther Toxicol. 1982 Jul;20(7):320–326. [PubMed] [Google Scholar]
- Spencer P. S. Review of the pharmacology of existing antidepressants. Br J Clin Pharmacol. 1977;4(Suppl 2):57S–68S. doi: 10.1111/j.1365-2125.1977.tb05761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turner P. Critical flicker frequency and centrally-acting drugs. Br J Ophthalmol. 1968 Mar;52(3):245–250. doi: 10.1136/bjo.52.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weissler A. M., Harris W. S., Schoenfeld C. D. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol. 1969 Apr;23(4):577–583. doi: 10.1016/0002-9149(69)90012-5. [DOI] [PubMed] [Google Scholar]